BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28301479)

  • 1. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.
    Conrad NL; Cruz McBride FW; Souza JD; Silveira MM; Félix S; Mendonça KS; Santos CS; Athanazio DA; Medeiros MA; Reis MG; Dellagostin OA; McBride AJ
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005441. PubMed ID: 28301479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera.
    da Cunha CEP; Bettin EB; Bakry AFAAY; Seixas Neto ACP; Amaral MG; Dellagostin OA
    Vaccine; 2019 Mar; 37(13):1844-1852. PubMed ID: 30826147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.
    Monaris D; Sbrogio-Almeida ME; Dib CC; Canhamero TA; Souza GO; Vasconcellos SA; Ferreira LC; Abreu PA
    Clin Vaccine Immunol; 2015 Aug; 22(8):965-73. PubMed ID: 26108285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.
    Forster KM; Hartwig DD; Oliveira TL; Bacelo KL; Schuch R; Amaral MG; Dellagostin OA
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):989-95. PubMed ID: 26676320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF
    Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine Immune Response to Vaccination and Infection with Leptospira borgpetersenii Serovar Hardjo.
    Wilson-Welder JH; Alt DP; Nally JE; Olsen SC
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33762318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    Evangelista KV; Lourdault K; Matsunaga J; Haake DA
    PLoS One; 2017; 12(7):e0180004. PubMed ID: 28704385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates.
    Maia MAC; Bettin EB; Barbosa LN; de Oliveira NR; Bunde TT; Pedra ACK; Rosa GA; da Rosa EEB; Seixas Neto ACP; Grassmann AA; McFadden J; Dellagostin OA; McBride AJA
    Front Cell Infect Microbiol; 2022; 12():940966. PubMed ID: 36275031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant vaccines against leptospirosis.
    Dellagostin OA; Grassmann AA; Hartwig DD; Félix SR; da Silva ÉF; McBride AJ
    Hum Vaccin; 2011 Nov; 7(11):1215-24. PubMed ID: 22048111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.
    Silva EF; Medeiros MA; McBride AJ; Matsunaga J; Esteves GS; Ramos JG; Santos CS; Croda J; Homma A; Dellagostin OA; Haake DA; Reis MG; Ko AI
    Vaccine; 2007 Aug; 25(33):6277-86. PubMed ID: 17629368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Immunoprotection of Leptospira Recombinant Proteins with conventional vaccine in experimental animals.
    Parthiban M; Kumar SS; Balachandran C; Kumanan K; Aarthi KS; Nireesha G
    Indian J Exp Biol; 2015 Dec; 53(12):779-85. PubMed ID: 26742322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection between experimental anti-leptospirosis bacterins.
    Dib CC; Gonçales AP; de Morais ZM; de Souza GO; Miraglia F; Abreu PA; Vasconcellos SA
    Braz J Microbiol; 2014; 45(3):1083-8. PubMed ID: 25477946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprotective Activity Induced by Leptospiral Outer Membrane Proteins in Hamster Model of Acute Leptospirosis.
    Teixeira AF; Cavenague MF; Kochi LT; Fernandes LG; Souza GO; de Souza Filho AF; Vasconcellos SA; Heinemann MB; Nascimento ALTO
    Front Immunol; 2020; 11():568694. PubMed ID: 33193344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model.
    Lucas DS; Cullen PA; Lo M; Srikram A; Sermswan RW; Adler B
    Vaccine; 2011 Apr; 29(18):3413-8. PubMed ID: 21396409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection.
    Garba B; Bahaman AR; Zakaria Z; Bejo SK; Mutalib AR; Bande F; Suleiman N
    Microb Pathog; 2018 Nov; 124():136-144. PubMed ID: 30138761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model.
    Yan W; Faisal SM; McDonough SP; Divers TJ; Barr SC; Chang CF; Pan MJ; Chang YF
    Microbes Infect; 2009 Feb; 11(2):230-7. PubMed ID: 19070678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System.
    Umthong S; Buaklin A; Jacquet A; Sangjun N; Kerdkaew R; Patarakul K; Palaga T
    J Microbiol Biotechnol; 2015 Apr; 25(4):526-36. PubMed ID: 25348693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis.
    Bacelo KL; Hartwig DD; Seixas FK; Schuch R; Moreira Ada S; Amaral M; Collares T; Vendrusculo CT; McBride AJ; Dellagostin OA
    Biomed Res Int; 2014; 2014():636491. PubMed ID: 24895594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity.
    Faisal SM; Yan W; McDonough SP; Chang YF
    Vaccine; 2009 Jan; 27(3):378-87. PubMed ID: 19022317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis.
    Hartwig DD; Forster KM; Oliveira TL; Amaral M; McBride AJ; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):747-52. PubMed ID: 23515012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.